Coalescence Partners Investment Management LP increased its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 47.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 74,916 shares of the semiconductor company’s stock after purchasing an additional 24,085 shares during the quarter. Synopsys accounts for 9.6% of Coalescence Partners Investment Management LP’s investment portfolio, making the stock its 5th biggest position. Coalescence Partners Investment Management LP’s holdings in Synopsys were worth $36,963,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in SNPS. Norges Bank bought a new stake in shares of Synopsys in the 2nd quarter valued at about $647,964,000. Ameriprise Financial Inc. increased its stake in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Synopsys by 177.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock valued at $427,269,000 after purchasing an additional 553,924 shares during the last quarter. Ninety One UK Ltd purchased a new stake in shares of Synopsys during the third quarter valued at approximately $249,851,000. Finally, Aspex Management HK Ltd grew its holdings in shares of Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after purchasing an additional 332,364 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. BNP Paribas assumed coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price on the stock. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and decreased their target price for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their price target for the company from $525.00 to $500.00 in a report on Monday, December 8th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $553.57.
Synopsys Stock Performance
Synopsys stock opened at $510.97 on Wednesday. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $97.76 billion, a P/E ratio of 63.95, a PEG ratio of 4.30 and a beta of 1.12. The stock’s 50 day moving average is $459.97 and its 200 day moving average is $504.36.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the company posted $3.40 earnings per share. The company’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Insider Buying and Selling at Synopsys
In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock valued at $1,945,036 in the last 90 days. Company insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
